Uncategorized

Accelus Announces New Milestone with Its FlareHawk® Interbody Fusion System Surpassing 15,000 Devices Implanted

PALM BEACH GARDENS, Fla., October 10, 2022 – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that more than 15,000 FlareHawk® multiplanar expandable cages have been implanted in more than 11,000 patients in the United States. “FlareHawk …

Accelus Announces New Milestone with Its FlareHawk® Interbody Fusion System Surpassing 15,000 Devices Implanted Read More »

Accelus Announces First Surgeries Using FlareHawk® TiHawk11™ Interbody Fusion System

New expandable interbody enables up to a 34mm-wide footprint from a posterior approach with up to 2cm2 of bone graft contact area through the implant PALM BEACH GARDENS, Fla., August 15, 2022 – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care …

Accelus Announces First Surgeries Using FlareHawk® TiHawk11™ Interbody Fusion System Read More »

Accelus Announces Vail-Summit Orthopaedics and Neurosurgery as First Ambulatory Surgery Center to Adopt Remi™ Robotic Navigation System

PALM BEACH GARDENS, Fla., July 14, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced Vail-Summit Orthopaedics and Neurosurgery (VSON) as the first ambulatory surgery center (ASC) to acquire the Remi Robotic Navigation System, …

Accelus Announces Vail-Summit Orthopaedics and Neurosurgery as First Ambulatory Surgery Center to Adopt Remi™ Robotic Navigation System Read More »

Accelus Announces Series D Equity Financing Led by Concord Health Partners (CHP)

CHP Co-Founder and Partner Joseph Swedish Named to Accelus Board of Directors PALM BEACH GARDENS, Fla., July 12, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the closing of a $12 million lead …

Accelus Announces Series D Equity Financing Led by Concord Health Partners (CHP) Read More »

Accelus Announces Sales Leadership Appointments, Establishes U.S. East and West Sales Leaders

All New Gallery Lisa Jacobs promoted to serve as Vice President of Sales Jim Fox promoted to East U.S. Vice President of Sales Jay Shellhammer promoted to West U.S. Vice President of Sales PALM BEACH GARDENS, Fla., June 13, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption …

Accelus Announces Sales Leadership Appointments, Establishes U.S. East and West Sales Leaders Read More »

Accelus Announces Opening of New Facilities in Colorado and California

New offices provide additional resources for clinical education, surgical training, and robotic research and development PALM BEACH GARDENS, Fla., May 26, 2022 – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the opening of its new robotic …

Accelus Announces Opening of New Facilities in Colorado and California Read More »

Accelus Receives U.S. FDA 510(k) Clearance for its Toro-L Interbody Fusion System

PALM BEACH GARDENS, Fla., May 19, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Toro Lateral (Toro-L) …

Accelus Receives U.S. FDA 510(k) Clearance for its Toro-L Interbody Fusion System Read More »

Accelus Receives U.S. FDA 510(k) Clearance for its FlareHawk TiHawk11 Interbody Fusion System

PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its FlareHawk TiHawk™11 Interbody …

Accelus Receives U.S. FDA 510(k) Clearance for its FlareHawk TiHawk11 Interbody Fusion System Read More »

Accelus Launches TiHawk7™ Titanium-Bonded Multidirectionally Expanding Interbody Cage to Support Endoscopic and MIS Lumbar Fusion Procedures

TiHawk7 combines ultra-low 7mm insertion profile with strong titanium/PEEK adhesion while still allowing for radiographic verification of fusion PALM BEACH GARDENS, Fla., May 5, 2022 (GLOBE NEWSWIRE) – Accelus, a medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced the alpha launch …

Accelus Launches TiHawk7™ Titanium-Bonded Multidirectionally Expanding Interbody Cage to Support Endoscopic and MIS Lumbar Fusion Procedures Read More »

Sun Sentinel Names Accelus a Winner of the South Florida Top Workplaces 2022 Award

Leading medical technology company recognized for employee engagement and culture PALM BEACH GARDENS, Fla., May 02, 2022 (GLOBE NEWSWIRE) — Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that it has been recognized by The Sun Sentinel …

Sun Sentinel Names Accelus a Winner of the South Florida Top Workplaces 2022 Award Read More »